Neisseria meningitidis serogroup B: laboratory correlates of protection (original) (raw)
Standardisation and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group
Daniel Libutti
Clinical and Diagnostic Laboratory Immunology
View PDFchevron_right
Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group
Daniel Libutti
Clinical and diagnostic laboratory immunology, 1997
View PDFchevron_right
Immune Responses against Major Outer Membrane Antigens of Neisseria meningitidis in Vaccinees and Controls Who Contracted Meningococcal Disease during the Norwegian Serogroup B Protection Trial
Einar Rosenqvist
Infection and Immunity, 1998
View PDFchevron_right
Standardization and a Multilaboratory Comparison ofNeisseria meningitidisSerogroup A and C Serum Bactericidal Assays
Daniel Libutti
1997
View PDFchevron_right
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005
Ingeborg Aaberge
Vaccine, 2006
View PDFchevron_right
ImmuneResponse ofBrazilian Children toaNeisseria meningitidis Serogroup B OuterMembraneProtein Vaccine: Comparison withEfficacy
Glacus Brito
1994
View PDFchevron_right
Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac
Stephen Taylor, Andrew Gorringe
Infection and Immunity, 2007
View PDFchevron_right
Seroprevalence and Placental Transmission of Maternal Antibodies Specific for Neisseria meningitidis Serogroups A, C, Y and W135 and Influence of Maternal Antibodies on the Immune Response to a Primary Course of MenACWY-CRM Vaccine in the United Kingdom
Elizabeth Kibwana
Pediatric Infectious Disease Journal, 2013
View PDFchevron_right
Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine
George Carlone
Infection and immunity, 1998
View PDFchevron_right
Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12-23 Months Following Meningococcal Vaccination
George Carlone
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015
View PDFchevron_right
Assignment of Neisseria meningitidis Serogroups A, C, W135, and Y Anticapsular Total Immunoglobulin G (IgG), IgG1, and IgG2 Concentrations to Reference Sera
Josantony Joseph
Clinical and Vaccine Immunology, 2004
View PDFchevron_right
Neisseria meningitidis B vaccines
D. Amicizia
Expert Review of Vaccines, 2011
View PDFchevron_right
serum bactericidal activity and protection against group B meningococci
salvatore papasergi
View PDFchevron_right
Comparison of Phenotypically Indistinguishable but Geographically Distinct Neisseria meningitidis Group B Isolates in a Serum Bactericidal Antibody Assay
Jan Poolman
Clinical and Vaccine Immunology, 2007
View PDFchevron_right
Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source
Lisa DeTora
Vaccine, 2011
View PDFchevron_right
Immunogenicity, Reactogenicity, and Safety of a P1.7b,4 Strain-Specific Serogroup B Meningococcal Vaccine Given to Preteens
Joanna Stewart, Ingeborg Aaberge
Clinical and Vaccine Immunology, 2007
View PDFchevron_right
Seroprevalence of antibodies against fHbp and NadA, two potential vaccine antigens for Neisseria meningitidis
Paula Molling
Vaccine, 2009
View PDFchevron_right
Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine
David Barroso
FEMS Immunology & Medical Microbiology, 2000
View PDFchevron_right
Assay Parameters and Methods of Data Analysis for the Comparison of Complement Sources in the Neisseria meningitidis Serogroup C Serum Bactericidal Assay
Luis Jodar
Biologicals, 2002
View PDFchevron_right
Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different …
Javier Díez-Domingo
JAMA: The Journal of …, 2012
View PDFchevron_right
Effectiveness of a Serogroup B and C Meningococcal Vaccine Developed in Cuba
Vicente Vérez Bencomo
MEDICC Review, 2018
View PDFchevron_right
Humoral Immune Responses to Neisseria meningitidis in Children
Simon Nadel
Infection and Immunity
View PDFchevron_right
Naturally-acquired immunity to Neisseria meningitidis group A
Jacob Amir
Vaccine, 2005
View PDFchevron_right
Evaluation of bactericidal activity of monoclonal antibodies obtained from Neisseria meningitidis
Valerie Ferro
2018
View PDFchevron_right
Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine
Pieter Van Gageldonk
PloS one, 2010
View PDFchevron_right
Critical analysis of old and new vaccines against N. meningitidis serogroup C, considering the meningococcal disease epidemiology in Brazil
Lucia Bricks
REVISTA-HOSPITAL DAS CLINICAS FACULDADE DE …, 2003
View PDFchevron_right
Vaccines for the prevention of meningococcal disease in children
M. Soriano-gabarró
Seminars in Pediatric Infectious Diseases, 2002
View PDFchevron_right
Specificity of Bactericidal Antibody Response to Serogroup B Meningococcal Strains in Brazilian Children after Immunization with an Outer Membrane Vaccine
Maurício Rodrigues
1998
View PDFchevron_right
Neisseria meningitidis Serogroup B Vaccine, Bivalent rLP2086, Induces Broad Serum Bactericidal Activity Against Diverse Invasive Disease Strains Including Outbreak Strains
Robert G K Donald
The Pediatric infectious disease journal, 2017
View PDFchevron_right
Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children
Jeff Bezos
The Journal of Pediatrics, 1996
View PDFchevron_right
Young-adult carriers of Neisseria meningitidis in Puglia (Italy): Will the pattern of circulating meningococci change following the introduction of meningococcal serogroup C conjugate vaccines?
Domenico Martinelli
Human Vaccines, 2010
View PDFchevron_right